Literature DB >> 24391418

Participation rates in cervical cancer screening: experience in rural Northern Greece.

A Vakfari1, M Gavana1, S Giannakopoulos1, E Smyrnakis1, A Benos1.   

Abstract

BACKGROUND AND AIM: Cervical cancer is one of the most common causes of cancer mortality among women worldwide but it is one of the most preventable cancers due to the Pap smear test. The aim of this study was to estimate the participation rate of females in screening of cervical cancer with Pap smear test.
METHODS: The study took place in a hospital in Rural Northern Greece during April and May 2007. Convenience sampling was performed and questionnaires were completed by 214 eligible females aged 20-64 years.
RESULTS: One hundred and twenty four (57.9%) of the participants had had a Pap-test at some point in their lifetime. 72 of them (33.65%) had the test performed for the first time according to current guidelines. 13.6% were unaware about the recommended onset age of the test, 16.4% did not know the proper intervals, while 22.4% did not know the recommended upper age limit. 32.6% were informed by mass media, family members and friends. The take-up rates, the source of information and the setting where the examination was performed were related to age, origin, income, educational status, type of occupation and place of residence. Disparities in participation rates were detected.
CONCLUSIONS: Special efforts should be made by National Health Services towards enhancing secondary prevention of cervical cancer by increasing participation rates of older women, those with lower educational background, females with low income, Roma, retired or unemployed and residents of rural areas.

Entities:  

Keywords:  Pap smear test; cervical cancer; participation rate; screening; secondary prevention

Year:  2011        PMID: 24391418      PMCID: PMC3876852     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  26 in total

1.  Attitudes to screening for cervical cancer: a population-based study in Sweden.

Authors:  S Eaker; H O Adami; P Sparén
Journal:  Cancer Causes Control       Date:  2001-08       Impact factor: 2.506

2.  Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost.

Authors:  Binh H Yang; Freddie I Bray; D Maxwell Parkin; John W Sellors; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

3.  Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.

Authors:  Jennifer S Smith; Rolando Herrero; Cristina Bosetti; Nubia Muñoz; F Xavier Bosch; José Eluf-Neto; Xavier Castellsagué; Chris J L M Meijer; Adriaan J C Van den Brule; Silvia Franceschi; Rhoda Ashley
Journal:  J Natl Cancer Inst       Date:  2002-11-06       Impact factor: 13.506

4.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

5.  Barriers to cervical cancer screening: a qualitative study with women in Serbia.

Authors:  Milica Markovic; Vesna Kesic; Lidija Topic; Bojana Matejic
Journal:  Soc Sci Med       Date:  2005-06-13       Impact factor: 4.634

6.  Meta-analysis of Pap test accuracy.

Authors:  M T Fahey; L Irwig; P Macaskill
Journal:  Am J Epidemiol       Date:  1995-04-01       Impact factor: 4.897

Review 7.  Socioeconomic differences in reproductive behaviour.

Authors:  I dos Santos Silva; V Beral
Journal:  IARC Sci Publ       Date:  1997

8.  Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.

Authors:  Victor Moreno; F Xavier Bosch; Nubia Muñoz; Chris J L M Meijer; Keerti V Shah; Jan M M Walboomers; Rolando Herrero; Silvia Franceschi
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

9.  [Use of pap smear for cervical cancer screening and factors related with its use in Spain].

Authors:  S Luengo Matos; A Muñoz van den Eynde
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

10.  Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Authors:  Joakim Dillner; Matejka Rebolj; Philippe Birembaut; Karl-Ulrich Petry; Anne Szarewski; Christian Munk; Silvia de Sanjose; Pontus Naucler; Belen Lloveras; Susanne Kjaer; Jack Cuzick; Marjolein van Ballegooijen; Christine Clavel; Thomas Iftner
Journal:  BMJ       Date:  2008-10-13
View more
  2 in total

1.  Level of Awareness Regarding Cervical Cancer Among Female Syrian Refugees in Greece.

Authors:  Vasiliki Dalla; Eirini-Kanella Panagiotopoulou; Anna Deltsidou; Maria Kalogeropoulou; Petros Kostagiolas; Dimitris Niakas; Georgios Labiris
Journal:  J Cancer Educ       Date:  2020-09-22       Impact factor: 1.771

2.  The association between social media use for health related information and compliance with breast and cervical cancer screenings.

Authors:  HyounKyoung G Park; Young-Il Kim; Warner K Huh; Sejong Bae
Journal:  Res Rep (Montgomery, Ala.)       Date:  2020-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.